GlassScriptPhysician profile
Ruth A Henchey
NPI 1235113275
$1,176.44
in general payments reported to CMS, 2019-2025
14 companies · $47.46 in 2025
The $47.46 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $112 · 2021: $176 · 2022: $201 · 2023: $194 · 2024: $245 · 2025: $47.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.60 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $575.50 | 2021-2024 | |
| Emd Serono, INC. | $125.58 | 2019-2020 | |
| Pfizer INC. | $84.56 | 2023-2024 | |
| Mdd US Operations, LLC | $69.05 | 2019-2020 | |
| Ge Healthcare | $63.82 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $50.99 | 2019-2020 | |
| Allergan, INC. | $44.81 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $34.13 | 2021 | |
| Nevro Corp. | $28.27 | 2023 | Senza |
| Genzyme Corporation | $24.21 | 2025 | |
| Livanova USA, INC. | $22.64 | 2020 | |
| Biogen, INC. | $19.79 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 | |
| Ucb, INC. | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Henchey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.